未登录

M

Micaël Hardy

umr 7273

H指数:32

被引数:5,443

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Redox and structural determinants of mitochondrial complex III inhibition by triphenylphosphonium-conjugated atovaquone analogs

三苯基膦共轭阿托喹酮类似物抑制线粒体复合物III的氧化还原和结构决定因素

IF11.9

2026-08-280

OAAI

Microbial Metabolism of Levodopa as an Adjunct Therapeutic Target in Parkinson’s Disease

IF6.6

2026-01-170

OAAI

One pot synthesis of ZnO nanoparticle/mesoporous silica nanocomposite for photocatalysis

一锅法制备用于光催化的ZnO纳米粒子/介孔二氧化硅纳米复合材料

Materials Chemistry and Physics

IF4.7

2025-10-240

PRE

The role of short-chain fatty acids in cancer prevention and cancer treatment

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

IF3

2024-11-014

OAAI

Mitigating gut microbial degradation of levodopa and enhancing brain dopamine: Implications in Parkinson's disease

COMMUNICATIONS BIOLOGY

IF5.1

2024-05-301

OAAI

Characterizing OXPHOS inhibitor-mediated alleviation of hypoxia using high-throughput live cell-imaging

CANCER & METABOLISM

IF5.3

2024-05-033

OAAI

Redox-crippled MitoQ potently inhibits breast cancer and glioma cell proliferation: A negative control for verifying the antioxidant mechanism of MitoQ in cancer and other oxidative pathologies

FREE RADICAL BIOLOGY AND MEDICINE

IF8.2

2023-08-012

OAAI

Preparation and In Vitro Validation of a Cucurbit[7]uril-Peptide Conjugate Targeting the LDL Receptor

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2023-06-208

OA

Antiproliferative effects of mitochondria-targeted N-acetylcysteine and analogs in cancer cells

SCIENTIFIC REPORTS

IF3.9

2023-05-042

OAAI

EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells

IF4.6

2022-09-107

OAAI

Therapeutic Targeting of Tumor Cells and Tumor Immune Microenvironment Vulnerabilities

FRONTIERS IN ONCOLOGY

IF3.3

2022-06-0814

OAAI

Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation

SCIENTIFIC REPORTS

IF3.9

2022-03-2411

OAAI

Prevention of Tumor Growth and Dissemination by In Situ Vaccination with Mitochondria-Targeted Atovaquone

通过线粒体靶向的Atovaquone原位疫苗预防肿瘤的生长和传播

ADVANCED SCIENCE

IF14.1

2022-03-0426

OAAI

Bioenergetic evaluation of Mito-compound Mito-Met as potent cytotoxic agents in gastric cancer

MOLECULAR CANCER THERAPEUTICS

IF5.5

2021-12-010

PRE

Oxidation of ethidium-based probes by biological radicals: mechanism, kinetics and implications for the detection of superoxide

SCIENTIFIC REPORTS

IF3.9

2020-10-2919

OAAI

Potent inhibition of tumour cell proliferation and immunoregulatory function by mitochondria-targeted atovaquone

SCIENTIFIC REPORTS

IF3.9

2020-10-2136

OAAI

Targeting metabolic reprogramming and OXPHOS as a viable anti-melanoma strategy

CANCER RESEARCH

IF16.6

2019-07-010

PRE

Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis

将洛尼达明靶向线粒体减轻肺癌发生和脑转移

NATURE COMMUNICATIONS

IF15.7

2019-05-17169

OAAI

Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals

IF3.3

2019-01-0118

PREAI

Detection of mitochondria-generated reactive oxygen species in cells using multiple probes and methods: Potentials, pitfalls, and the future

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2018-06-0177

OAAI